dbSNP rs1208: NAT2:p.Arg268Lys (chr8-18400806-G-A) – ACMG Classification: Benign (-13 pts)

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_000015.3(NAT2):c.803G>A(p.Arg268Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.592 in 1,610,782 control chromosomes in the GnomAD database, including 286,455 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).

Frequency

Genomes: 𝑓 0.60 ( 28055 hom., cov: 31)

Exomes 𝑓: 0.59 ( 258400 hom. )

Consequence

NAT2
NM_000015.3 missense

Scores

Clinical Significance

Likely benign no assertion criteria provided B:1

Conservation

PhyloP100: 0.0830

Publications

297 publications found

Variant links:

Genes affected

NAT2 (HGNC:7646): (N-acetyltransferase 2) This gene encodes an enzyme that functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in this gene are responsible for the N-acetylation polymorphism in which human populations segregate into rapid, intermediate, and slow acetylator phenotypes. Polymorphisms in this gene are also associated with higher incidences of cancer and drug toxicity. A second polymorphic arylamine N-acetyltransferase gene (NAT1), is located near this gene (NAT2). [provided by RefSeq, Sep 2019]

NAT2 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4

Computational evidence support a benign effect (MetaRNN=6.8380643E-7).

BP6

Variant 8-18400806-G-A is Benign according to our data. Variant chr8-18400806-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 3059207.Status of the report is no_assertion_criteria_provided, 0 stars.

BA1

GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.938 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
NAT2	NM_000015.3 link	c.803G>A	p.Arg268Lys	missense_variant	Exon 2 of 2	ENST00000286479.4	NP_000006.2
NAT2	XM_017012938.2 link	c.803G>A	p.Arg268Lys	missense_variant	Exon 3 of 3		XP_016868427.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
NAT2	ENST00000286479.4 link	c.803G>A	p.Arg268Lys	missense_variant	Exon 2 of 2	1	NM_000015.3	ENSP00000286479.3
NAT2	ENST00000520116.1 link	c.413G>A	p.Arg138Lys	missense_variant	Exon 2 of 2	3		ENSP00000428416.1

Frequencies

GnomAD3 genomes

AF:

0.602

AC:

91371

AN:

151750

Hom.:

28047

Cov.:

show subpopulations

Gnomad AFR

AF:

0.601

Gnomad AMI

AF:

0.677

Gnomad AMR

AF:

0.635

Gnomad ASJ

AF:

0.559

Gnomad EAS

AF:

0.960

Gnomad SAS

AF:

0.650

Gnomad FIN

AF:

0.553

Gnomad MID

AF:

0.538

Gnomad NFE

AF:

0.574

Gnomad OTH

AF:

0.594

GnomAD2 exomes

AF:

0.619

AC:

153259

AN:

247584

AF XY:

0.617

show subpopulations

Gnomad AFR exome

AF:

0.597

Gnomad AMR exome

AF:

0.657

Gnomad ASJ exome

AF:

0.558

Gnomad EAS exome

AF:

0.959

Gnomad FIN exome

AF:

0.558

Gnomad NFE exome

AF:

0.567

Gnomad OTH exome

AF:

0.587

GnomAD4 exome

AF:

0.591

AC:

862387

AN:

1458914

Hom.:

258400

Cov.:

AF XY:

0.592

AC XY:

429292

AN XY:

725744

show subpopulations

African (AFR)

AF:

0.595

AC:

19826

AN:

33324

American (AMR)

AF:

0.655

AC:

29011

AN:

44264

Ashkenazi Jewish (ASJ)

AF:

0.565

AC:

14709

AN:

26048

East Asian (EAS)

AF:

0.965

AC:

38277

AN:

39680

South Asian (SAS)

AF:

0.646

AC:

55345

AN:

85722

European-Finnish (FIN)

AF:

0.563

AC:

29812

AN:

52942

Middle Eastern (MID)

AF:

0.543

AC:

3124

AN:

5754

European-Non Finnish (NFE)

AF:

0.573

AC:

636098

AN:

1110896

Other (OTH)

AF:

0.600

AC:

36185

AN:

60284

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.473

Heterozygous variant carriers

16921

33842

50764

67685

84606

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Exome Hom

Variant carriers

17850

35700

53550

71400

89250

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.602

AC:

91412

AN:

151868

Hom.:

28055

Cov.:

AF XY:

0.604

AC XY:

44838

AN XY:

74208

show subpopulations

African (AFR)

AF:

0.600

AC:

24861

AN:

41406

American (AMR)

AF:

0.635

AC:

9688

AN:

15260

Ashkenazi Jewish (ASJ)

AF:

0.559

AC:

1940

AN:

3468

East Asian (EAS)

AF:

0.960

AC:

4925

AN:

5130

South Asian (SAS)

AF:

0.649

AC:

3128

AN:

4818

European-Finnish (FIN)

AF:

0.553

AC:

5825

AN:

10534

Middle Eastern (MID)

AF:

0.531

AC:

155

AN:

292

European-Non Finnish (NFE)

AF:

0.574

AC:

39012

AN:

67938

Other (OTH)

AF:

0.598

AC:

1262

AN:

2112

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.503

Heterozygous variant carriers

1809

3618

5428

7237

9046

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Genome Hom

Variant carriers

766

1532

2298

3064

3830

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.583

Hom.:

92509

Bravo

AF:

0.607

TwinsUK

AF:

0.572

AC:

2120

ALSPAC

AF:

0.581

AC:

2238

ESP6500AA

AF:

0.601

AC:

2646

ESP6500EA

AF:

0.576

AC:

4951

ExAC

AF:

0.615

AC:

74582

Asia WGS

AF:

0.779

AC:

2709

AN:

3478

EpiCase

AF:

0.570

EpiControl

AF:

0.572

ClinVar

Significance: Likely benign

Submissions summary: Benign:1

Revision: no assertion criteria provided

LINK: link

Submissions by phenotype

NAT2-related disorder

Benign:1

Nov 06, 2019

PreventionGenetics, part of Exact Sciences

Significance:Likely benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

AlphaMissense

Benign

0.067

BayesDel_addAF

Benign

-0.84

BayesDel_noAF

Benign

-0.83

CADD

Benign

1.3

(source)

DANN

Benign

0.24

DEOGEN2

Benign

0.0040

.;T

Eigen

Benign

-1.3

Eigen_PC

Benign

-1.3

FATHMM_MKL

Benign

0.0028

LIST_S2

Benign

0.035

T;T

MetaRNN

Benign

6.8e-7

T;T

MetaSVM

Benign

-1.0

PhyloP100

0.083

PrimateAI

Benign

0.35

PROVEAN

Benign

1.4

N;N

REVEL

Benign

0.041

Sift

Benign

1.0

T;T

Sift4G

Benign

1.0

T;T

Polyphen

0.0

B;.

Vest4

0.013

MPC

0.0046

ClinPred

0.000022

GERP RS

1.5

gMVP

0.47

Mutation Taster

=99/1

polymorphism (auto)

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over